Jesica Mazza-Stalder

Recent Contributions

Reply to [ARCHIVED] New Medicines and Novel Approaches for MDR-TB

March 26, 2014
Hello It is possible that we might use Bedaquiline with an XDR patient soon. Does anybody know if we can monitor levels of Bedaquiline while on trial? Many thanks Jesica CHUV centre hospitalier universitaire vaudois Dr. Jesica Mazza-Stalder Médecin agréé Service de Pneumologie Bugnon 46 - 1011 Lausanne Tél. +41 ...

Reply to [ARCHIVED] New Medicines and Novel Approaches for MDR-TB

March 19, 2014
I'will like to join you for the discussion. Many thanks for the invitation. Kind regards Jesica Mazza-Stalder MD Senior consultant lung specialist University Hospital of Lausanne (CHUV) Switzerland

Isolation policies of TB-MDR a question to ED Nardell

Feb. 28, 2014
Hi, Ed I will like to ask you if your data on MDR patients that reproduces the experiment done in Guinea pigs by Rilley has been published yet? I've seen your comments in 2012 about this matter and you show some data about a pilot study in South Africa. Can ...
Keywords:
Guidelines Publications & Research

Reply to Start of 2013 and short introduction of members

Jan. 10, 2013
Jesica Mazza-Staéder, MD, pneumologist. Staff member and co-responsable of the tuberculosis center in Lausanne University Hospital, CHUV, advisor of the "Ligue pulmonaire vaudoise"and Public health (VD canton) in Tb matters. Researcher in the field of new diagnostic technics in tuberculosis and other subjects. CHUV centre hospitalier universitaire vaudois Dr. Jesica ...


Recent Recommendations

None at this time.